Who makes Coenzyme Q10 100 Milligrams Oral Capsule?

Coenzyme Q10 100 Milligrams Oral Capsule is developed by Ain Shams University.

What development phase is Coenzyme Q10 100 Milligrams Oral Capsule in?

Coenzyme Q10 100 Milligrams Oral Capsule is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

Coenzyme Q10 100 Milligrams Oral Capsule

Ain Shams University · FDA-approved active Small molecule Quality 2/100

At a glance

Generic name	Coenzyme Q10 100 Milligrams Oral Capsule
Also known as	Coenzyme Q10
Sponsor	Ain Shams University
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

A Danish Pragmatic Randomized Trial of Nutritional Supplements in Heart Failure (PHASE3)
Coenzyme Q10 Role in Prevention of Contrast Induced Nephropathy in Acute Coronary Syndrome Patients. (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Coenzyme Q10 100 Milligrams Oral Capsule CI brief — competitive landscape report
Coenzyme Q10 100 Milligrams Oral Capsule updates RSS · CI watch RSS
Ain Shams University portfolio CI